In vivo imaging of tau pathology using multi-parametric quantitative MRI.
Ontology highlight
ABSTRACT: As the number of people diagnosed with Alzheimer's disease (AD) reaches epidemic proportions, there is an urgent need to develop effective treatment strategies to tackle the social and economic costs of this fatal condition. Dozens of candidate therapeutics are currently being tested in clinical trials, and compounds targeting the aberrant accumulation of tau proteins into neurofibrillary tangles (NFTs) are the focus of substantial current interest. Reliable, translatable biomarkers sensitive to both tau pathology and its modulation by treatment along with animal models that faithfully reflect aspects of the human disease are urgently required. Magnetic resonance imaging (MRI) is well established as a valuable tool for monitoring the structural brain changes that accompany AD progression.
SUBMITTER: Wells JA
PROVIDER: S-EPMC4626540 | biostudies-literature | 2015 May
REPOSITORIES: biostudies-literature
ACCESS DATA